An injury to the central nervous system or the brain can significantly affect a person’s ability to perform a variety of day to day tasks or activities. Neurorehabilitation helps improve the patient’s ability to function independently after he is diagnosed with conditions such as stroke, multiple sclerosis, brain tumor, Parkinson’s disease, epilepsy, and traumatic brain injury. Neurorehabilitation is a multi-modal, multi-disciplinary approach to help such patients to improve their physiological functioning. Neurorehabilitation can be broadly classified into three coordinated phases, viz. intermediate care, acute rehabilitation, and occupational rehabilitation. Patients undergoing neurorehabilitation usually go through more than one of these phases.
Acquired brain injuries severely affect the neurological functioning of patients especially in early stage. Such effects could range from dysphagia, in which patients have difficulty in swallowing, impaired consciousness to immobility (paralysis). In intermediate care, the focus is on restoring and improving the basic bodily functions. This involves, ensuring that the patient can ingest food and breath, stabilizing the circulation, preventing muscle stiffness and self-injury, and prevent the distressing effects of anxiety and restlessness. In acute rehabilitation, along with improving patients’ mental and physical capabilities, the therapy is focused towards enabling patients to gain independence in their daily life to perform their everyday activities. Once these patients are able to cope with everyday activities, the next challenge is to return to work. Occupational rehabilitation programs can be designed to improve patients’ stamina and physical condition. Such activities can ensure that the patient can perform his routine tasks with the required level of physical fitness and stamina.
Some of the key drivers for the growth of neurorehabilitation devices market are the increasing prevalence of neurological diseases such as cerebral palsy, stroke, multiple sclerosis, and brain injuries. According to the Parkinson’s Disease Foundation, nearly 60,000 Americans are diagnosed with Parkinson’s disease every year, excluding thousands of cases that go undetected. The increasing incidence of stroke can also be attributed to the rising demand for neurorehabilitation devices. As per the data revealed by the Center for Disease Control and Prevention (CDC) in May 2017, over 795,000 cases of stroke are reported every year in the U.S., of which around 610,000 cases are of first stroke. Such high prevalence of these neurological disorders will largely contribute to the demand for neurological rehabilitation devices over the coming years. However, the high cost of neurological rehabilitation treatments and a dearth of skilled professionals to operate sophisticated rehabilitation devices can hinder the growth of the neurorehabilitation devices market.
Technological advancements will spearhead the growth of neurorehabilitation devices market. Increasing integration of robotics in neurorehabilitation has further enhanced the efficiency of these procedures in early rehabilitation of the patients. Wearable exoskeletons are assisting the patients to perform physical activities with more ease and perfection which facilitates early recovery and rehabilitation. Such advancements will largely contribute to the demand for neurorehabilitation devices over coming years.
The major players in the neurorehabilitation devices market focus on product development to secure a larger share at global level. With development of technologically advanced products, these players facilitate further acceleration of the market growth. For instance, in February 2017, Bioness, Inc., one of the leading providers of rehabilitation therapies, obtained FDA clearance for its L300 Go System, the first functional electric stimulation system, which offers 3D motion detection of gait events along with muscle activation using data from an accelerometer and a 3-axis gyroscope. Some of the key players in this market are Bioness, Inc., Hocoma AG, Ectron Ltd, Tyromotion GmbH, St. Jude Medical, Inc., Medtronic plc, AlterG, Inc. and Ekso Bionics Holdings, Inc.
Neurorehabilitation Market Segmentation:
- Non-invasive Stimulators
- Wearable Devices
- Brain-computer Interface
- Traumatic Brain Injury
- Spinal Cord Injury
- Cerebral Palsy
- Parkinson’s Disease
- Rest of Europe
- South Korea
- Rest of Asia Pacific
- South Africa
- Saudi Arabia
- United Arab Emirates
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
Data Collection Matrix
Primary Data Sources
- Distributors & Wholesalers
- Healthcare Providers
Secondary Data Sources
- Annual Reports/SEC Filings/ Investor Presentations/ Press Releases
- Government/Associations Publications
- Case Studies
- Reference Customers
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Quantitative Data (2017-2025)
- Market Dynamics (Drivers, Restraints, and Challenges)
- Industry Trend Analysis
- Market Opportunities
- Government Policies and Regulations, Patent Analysis, and Reimbursement Policies
- Porter’s Five Forces and PESTLE Analysis
- Key Developments and Competitive Landscape
- Market Assessment and Forecast
- Market Assessment and Forecast, By Product
- Market Assessment and Forecast, By Technology
- Market Assessment and Forecast, By Application
- Market Assessment and Forecast, By End User
- Market Assessment and Forecast, By Region/Country